These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9167416)

  • 21. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
    Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
    Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging.
    Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Mov Disord; 2005 Dec; 20(12):1571-6. PubMed ID: 16116613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increase of total homocysteine concentration in cerebrospinal fluid in patients with Alzheimer's disease and Parkinson's disease.
    Isobe C; Murata T; Sato C; Terayama Y
    Life Sci; 2005 Aug; 77(15):1836-43. PubMed ID: 15935398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Depression and Parkinson disease].
    Errea JM; Ara JR
    Rev Neurol; 1999 Apr 1-15; 28(7):694-8. PubMed ID: 10363296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional ability correlates with cognitive impairment in Parkinson's disease and Alzheimer's disease.
    Sabbagh MN; Lahti T; Connor DJ; Caviness JN; Shill H; Vedders L; Mahant P; Samanta J; Burns RS; Evidente VG; Driver-Dunckley E; Reisberg B; Bircea S; Adler CH
    Dement Geriatr Cogn Disord; 2007; 24(5):327-34. PubMed ID: 17851237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What causes mental dysfunction in Parkinson's disease?
    Emre M
    Mov Disord; 2003 Sep; 18 Suppl 6():S63-71. PubMed ID: 14502658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuropsychological disorders in Parkinson's disease: evaluating them and their impact on the caregiver].
    Martínez-Martín P; Guerrero-Díaz MT; Frades-Payo B
    Rev Neurol; 2004 Oct 1-15; 39(7):639-45. PubMed ID: 15490351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Parkinson syndrome and cognitive disorders].
    Szirmai I; Kovács T
    Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of visual contrast sensitivity in Parkinson's disease.
    Skrandies W; Gottlob I
    Hum Neurobiol; 1986; 5(4):255-9. PubMed ID: 3028995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.
    Santangelo G; Vitale C; Trojano L; Verde F; Grossi D; Barone P
    Mov Disord; 2009 Apr; 24(6):899-905. PubMed ID: 19205072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
    Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
    Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease.
    Lunardi G; Galati S; Tropepi D; Moschella V; Brusa L; Pierantozzi M; Stefani A; Rossi S; Fornai F; Fedele E; Stanzione P; Hainsworth AH; Pisani A
    Parkinsonism Relat Disord; 2009 Jun; 15(5):383-9. PubMed ID: 19010710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Executive function in Parkinson's disease].
    Kanazawa A; Mizuno Y; Narabayashi H
    Rinsho Shinkeigaku; 2001; 41(4-5):167-72. PubMed ID: 11676156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impairment of social cognition in Parkinson disease--comparison of idiopathic Parkinson disease with juvenile parkinsonism].
    Yoshimura N
    Brain Nerve; 2007 Sep; 59(9):917-22. PubMed ID: 17886473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.